参考文献/References:
[1] Preshaw PM,de Silva N,McCracken GI,et al.Compromised periodontal status in an urban Sri Lankan population with type 2 diabetes[J].J Clin Periodontol,2010,37(2):165-171.DOI:10.1111/j.1600-051X.2009.01519.x.
[2] Choi YH,McKeown RE,Mayer-Davis EJ,et al.Association between periodontitis and impaired fasting glucose and diabetes[J].Diabetes Care,2011,34(2):381-386.DOI:10.2337/dc10-1354.
[3] Löe H.Periodontal disease. The sixth complication of diabetes mellitus[J].Diabetes Care,1993,16(1):329-334.
[4] Taylor GW,Burt BA,Becker MP,et al.Severe periodontitis and risk for poor glycemic control in patients with non-insulin-dependent diabetes mellitus[J].J Periodontol,1996,67(10 Suppl):1085-1093.DOI:10.1902/jop.1996.67.10s.1085.
[5] Kiran M,Arpak N,Unsal E,et al.The effect of improved periodontal health on metabolic control in type 2 diabetes mellitus[J].J Clin Periodontol,2005,32(3):266-272.
[6] Williams RC Jr,Mahan CJ.Periodontal disease and diabetes in young adults[J].J Am Med Assoc,1960,172:776-778.
[7] Miller LS,Manwell MA,Newbold D,et al.The relationship between reduction in periodontal inflammation and diabetes control: a report of 9 cases[J].J Periodontol,1992,63(10):843-848.DOI:10.1902/jop.1992.63.10.843.
[8] Grossi SG,Skrepcinski FB,DeCaro T,et al.Treatment of periodontal disease in diabetics reduces glycated hemoglobin[J].J Periodontol,1997,68(8):713-719.DOI:10.1902/jop.1997.68.8.713.
[9] Simpson TC,Weldon JC,Worthington HV,et al. Treatment of periodontal disease for glycaemic control in people with diabetes mellitus[J].Cochrane Database Syst Rev,2015,(11):CD004714.DOI:10.1002/14651858.CD004714.pub3.
[10] Keestra JA,Grosjean I,Coucke W,et al.Non-surgical periodontal therapy with systemic antibiotics in patients with untreated chronic periodontitis: a systematic review and meta-analysis[J].J Periodontal Res,2015,50(3):294-314.DOI:10.1111/jre.12221.
[11] Sgolastra F,Gatto R,Petrucci A,et al.Effectiveness of systemic amoxicillin/metronidazole as adjunctive therapy to scaling and root planing in the treatment of chronic periodontitis: a systematic review and meta-analysis[J].J Periodontol,2012,83(10):1257-1269.DOI:10.1902/jop.2012.110625.
[12] Grellmann AP,Sfreddo CS,Maier J,et al.Systemic antimicrobials adjuvant to periodontal therapy in diabetic subjects: a meta-analysis[J].J Clin Periodontol,2016,43(3):250-260.DOI:10.1111/jcpe.12514.
[13] Santos CM,Lira-Junior R,Fischer RG,et al. Systemic antibiotics in periodontal treatment of diabetic patients: a systematic review[J].PLoS One,2015,10(12):e0145262.DOI:10.1371/journal.pone.0145262.
[14] Grossi SG,Skrepcinski FB,DeCaro T,et al.Response to periodontal therapy in diabetics and smokers[J].J Periodontol,1996, 67(Suppl 10S):1094-1102.DOI:10.1902/jop.1996.67.10s.1094.
[15] Miranda TS,Feres M,Perez-Chaparro PJ,et al.Metronidazole and amoxicillin as adjuncts to scaling and root planing for the treatment of type 2 diabetic subjects with periodontitis: 1-year outcomes of a randomized placebo-controlled clinical trial[J].J Clin Periodontol,2014,41(9):890-899.DOI:10.1111/jcpe.12282.
[16] Al-Zahrani MS,Bamshmous SO,Alhassani AA,et al.Short-term effects of photodynamic therapy on periodontal status and glycemiccontrol of patients with diabetes[J].J Periodontol,2009,80(10):1568-1573.DOI:10.1902/jop.2009.090206.
[17] Rodrigues DC,Taba MJ,Novaes AB,et al.Effect of non-surgical periodontal therapy on glycemic control in patients with type 2 diabetes mellitus[J].J Periodontol,2003,74(9):1361-1367. DOI:10.1902/jop.2003.74.9.1361.
[18] Higgins J,Altman DG,Sterne JAC. Assessing risk of bias in included studies//Higgins J,Green S,eds. Cochrane handbook for systematic reviews of interventions[M]. 5.1.0.ed. Hoboken:John Wiley & Sons,Ltd,2011. Available from www.handbook.cochrane.org.
[19] Atkins D,Best D,Briss PA,et al.Grading quality of evidence and strength of recommendations[J].BMJ,2004,328(7454):1490.DOI:10.1136/bmj.328.7454.1490.
[20] Botero JE,Yepes FL,Ochoa SP,et al.Effects of periodontal non-surgical therapy plus azithromycin on glycemic control in patients with diabetes: a randomized clinical trial[J].J Periodontal Res,2013,48(6):706-712.DOI:10.1111/jre.12058.
[21] Engebretson SP,Hey-Hadavi J.Sub-antimicrobial doxycycline for periodontitis reduces hemoglobin A1c in subjects with type 2 diabetes: a pilot study[J].Pharmacol Res,2011,64(6):624-629.DOI:10.1016/j.phrs.2011.06.024.
[22] Gaikwad SP,Gurav AN,Shete AR,et al.Effect of scaling and root planing combined with systemic doxycycline therapy on glycemic control in diabetes mellitus subjects with chronic generalized periodontitis: a clinical study[J].J Periodontal Implant Sci,2013,43(2):79-86.DOI:10.5051/jpis.2013.43.2.79.
[23] Tsalikis L,Sakellari D,Dagalis P,et al.Effects of doxycycline on clinical, microbiological and immunological parameters in well-controlled diabetes type-2 patients with periodontal disease: a randomized, controlled clinical trial[J].J Clin Periodontol,2014,41(10):972-980.DOI:10.1111/jcpe.12287.
[24] Corbella S,Francetti L,Taschieri S,et al.Effect of periodontal treatment on glycemic control of patients with diabetes: a systematic review and meta-analysis[J].J Diabetes Investig,2013,4(5):502-509.DOI:10.1111/jdi.12088.
[25] Sgolastra F,Severino M,Pietropaoli D,et al.Effectiveness of periodontal treatment to improve metabolic control in patients with chronic periodontitis and type 2 diabetes: a meta-analysis of randomized clinical trials[J].J Periodontol,2013,84(7):958-973.DOI:10.1902/jop.2012.120377.
[26] Wang X,Han X,Guo X,et al.The effect of periodontal treatment on hemoglobin a1c levels of diabetic patients: a systematic review and meta-analysis[J].PLoS One,2014,9(9):e108412.DOI:10.1371/journal.pone.0108412.
[27] Zaura E,Brandt BW,Teixeira de Mattos MJ,et al.Same exposure but two radically different responses to antibiotics: resilience of the salivary microbiome versus long-term microbial shifts in feces[J].MBio,2015,6(6):e01693-1615.DOI:10.1128/mBio.01693-15.
[28] Hartstra AV,Bouter KE,Bäckhed F,et al.Insights into the role of the microbiome in obesity and type 2 diabetes[J].Diabetes Care,2015,38(1):159-165.DOI:10.2337/dc14-0.
[29] Amábile-Cuevas C.Society must seize control of the antibiotics crisis[J].Send to Nature,2016,533(7604):439.DOI:10.1038/533439a.
相似文献/References:
[1]赵紫琴,雒瑢,田凤石,等.替米沙坦对OLETF大鼠皮下和内脏脂肪组织PPARγ表达的影响[J].国际内分泌代谢杂志,2014,(06):365.[doi:10.3760/cma.j.issn.1673-4157.2014.06.002]
Zhao Ziqin*,Luo Rong,Tian Fengshi,et al.Effects of telmisartan on expression of PPARγ in subcutaneous and visceral adipose tissue in OLETF rats[J].International Journal of Endocrinology and Metabolism,2014,(04):365.[doi:10.3760/cma.j.issn.1673-4157.2014.06.002]
[2]姚霜霜,张翼飞,张志国,等.小檗碱改善代谢性疾病的肠道相关机制[J].国际内分泌代谢杂志,2014,(06):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
Yao Shuangshuang,Zhang Yifei,Zhang Zhiguo,et al.The gut-related mechanisms of berberine in the treatment of metabolic diseases[J].International Journal of Endocrinology and Metabolism,2014,(04):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
[3]曹萌 韦晓 刘超.自噬与胰岛β细胞功能及2型糖尿病[J].国际内分泌代谢杂志,2015,(01):53.[doi:10.3760/cma.j.issn.1673-4157.2015.01.013]
Cao Meng,Wei Xiao,Liu Chao..Relationship between autophagy and islet β cells function, type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(04):53.[doi:10.3760/cma.j.issn.1673-4157.2015.01.013]
[4]刘艳 田秀标 韩颖.GLP-1受体激动剂呈葡萄糖依赖性刺激胰岛β细胞胰岛素分泌的机制[J].国际内分泌代谢杂志,2015,(01):66.[doi:10.3760/cma.j.issn.1673-4157.2015.01.017]
Liu Yan*,Tian Xiubiao,Han Ying..Mechanism of GLP-1 receptor agonists in the stimulation of insulin secretion of islet β cell in a glucose-dependent manner[J].International Journal of Endocrinology and Metabolism,2015,(04):66.[doi:10.3760/cma.j.issn.1673-4157.2015.01.017]
[5]齐利琴,刘礼斌.GLP-1在2型糖尿病诱发的阿尔茨海默病治疗中的作用[J].国际内分泌代谢杂志,2016,36(01):48.[doi:10.3760/cma.j.issn.1673-4157.2016.01.012]
Qi Liqin,Liu Libin..Effects of GLP-1 in the treatment of Alzheimer's disease induced by type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2016,36(04):48.[doi:10.3760/cma.j.issn.1673-4157.2016.01.012]
[6]梅稳,向光大,卢俊颜,等.GDF11对ApoE-/-糖尿病小鼠内皮依赖性
血管舒张功能的作用[J].国际内分泌代谢杂志,2016,36(02):101.[doi:10.3760/cma.j.issn.1673-4157.2016.02.007]
Mei Wen*,Xiang Guangda,Lu Junyan,et al.Effects of GDF11 on endothelium-dependent vasodiation function of aorta in ApoE-/- diabetic mice[J].International Journal of Endocrinology and Metabolism,2016,36(04):101.[doi:10.3760/cma.j.issn.1673-4157.2016.02.007]
[7]殷俏,张云良,郭淑芹,等.视黄醇结合蛋白4、超敏C反应蛋白
与糖尿病视网膜病变的关系[J].国际内分泌代谢杂志,2016,36(03):149.[doi:10.3760/cma.j.issn.1673-4157.2016.03.02]
Yin Qiao,Zhang Yunliang,Guo Shuqin,et al.Relationship of retinol binding protein 4 and high sensitive C-reactive protein with diabetic retinopathy[J].International Journal of Endocrinology and Metabolism,2016,36(04):149.[doi:10.3760/cma.j.issn.1673-4157.2016.03.02]
[8]王涛,张洁,祁范范,等.不同糖耐量人群血清25(OH)D3水平
及与胰岛β细胞功能的关系[J].国际内分泌代谢杂志,2016,36(04):226.[doi:10.3760/cma.j.issn.1673-4157.2016.04.04]
Wang Tao*,Zhang Jie,Qi Fanfan,et al.Relationship between serum 25(OH)D3 level and islet β cell function in individuals with different glucose tolerance[J].International Journal of Endocrinology and Metabolism,2016,36(04):226.[doi:10.3760/cma.j.issn.1673-4157.2016.04.04]
[9]陈双双,王楚媛,孔令芳.铬与2型糖尿病[J].国际内分泌代谢杂志,2016,36(04):272.[doi:10.3760/cma.j.issn.1673-4157.2016.04.13]
Chen Shuangshuang,Wang Chuyuan,Kong Lingfang.Chromium and type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2016,36(04):272.[doi:10.3760/cma.j.issn.1673-4157.2016.04.13]
[10]涂萍,许婷,段鹏,等.25-羟维生素D3补充对绝经后2型糖尿病
患者胰岛素敏感性及血糖控制的影响[J].国际内分泌代谢杂志,2016,36(05):299.[doi:10.3760/cma.j.issn.1673-4157.2016.05.04]
Tu Ping,Xu Ting,Duan Peng,et al.Influence of 25-hydroxyvitamin D3 supplement on insulin sensitivity and glucose control in postmenopausal patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2016,36(04):299.[doi:10.3760/cma.j.issn.1673-4157.2016.05.04]